Trials / Completed
CompletedNCT01779856
Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.
Monitoring in Dialysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Medtronic Corporate Technologies and New Ventures · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to estimate the proportion of hemodialysis patients experiencing clinically significant cardiac arrhythmias over a 6-month period using continuous cardiac monitoring with an implanted Medtronic Reveal Insertable Cardiac Monitor (ICM) device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | REVEAL Insertable Cardiac Monitor (ICM) |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-07-01
- Completion
- 2015-09-01
- First posted
- 2013-01-30
- Last updated
- 2021-02-15
- Results posted
- 2021-02-15
Locations
10 sites across 2 countries: United States, India
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01779856. Inclusion in this directory is not an endorsement.